TY - JOUR
T1 - The effect of penetration enhancers on the kinetics of percutaneous absorption
AU - Guy, Richard H.
AU - Hadgraft, Jonathan
N1 - Funding Information:
Supported by N.I.H. grants GM-33395 and AG-04851, Ciba-Geigy and Vick International. R.H.G. is the recipient of a Special Emphasis Research Career Award (l-KOl-OH-00017) from the National Institute of Occupational Safety and Health. A partial account of this work was presented at the 12th International Symposium on the Controlled Release of Bioactive Materials in Geneva, Switzerland, 1985. We thank Elma Belenson for preparing the manuscript.
PY - 1987/6/30
Y1 - 1987/6/30
N2 - The effect of penetration enhancers on the kinetics of percutaneous absorption and transdermal drug delivery has been examined theoretically. Using a physically based pharmacokinetic description of skin absorption, the action of model promoters has been investigated as a function of the physicochemical properties of the penetrant. The kinetic simulation permits both zero- and first-order input of the drug from the delivery system; diffusion through the skin is modelled by consecutive transport steps across the stratum corneum and viable epidermis and by a partitioning process at the lipophilic-aqueous phase boundary between those two tissue layers. Two model enhancers, whose effects occur specifically in skin, are considered: the first (PE1) increases the drug diffusion coefficient (Ds) across the stratum corneum by an order of magnitude; the second (PE2) again increases Ds ten-fold but also reduces the effective stratum corneum-viable tissue partition coefficient of the drug to 10% of its unperturbed value. The action of these promoters is shown to be sensitive to the oil-water distribution characteristics of the drug: PE1 is effective for relatively hydrophilic compounds but becomes increasingly ineffectual as a drug lipophilicity increases (log K (moctanol/H2O)≥2); PE2, on the other hand, provides little additional effect over PE1 for hydrophilic substances but significantly enhances the transdermal delivery of hydrophobic moieties. It appears, therefore, that the desirable properties of a penetration enhancer may change depending upon the physico-chemical nature of the drug being delivered.
AB - The effect of penetration enhancers on the kinetics of percutaneous absorption and transdermal drug delivery has been examined theoretically. Using a physically based pharmacokinetic description of skin absorption, the action of model promoters has been investigated as a function of the physicochemical properties of the penetrant. The kinetic simulation permits both zero- and first-order input of the drug from the delivery system; diffusion through the skin is modelled by consecutive transport steps across the stratum corneum and viable epidermis and by a partitioning process at the lipophilic-aqueous phase boundary between those two tissue layers. Two model enhancers, whose effects occur specifically in skin, are considered: the first (PE1) increases the drug diffusion coefficient (Ds) across the stratum corneum by an order of magnitude; the second (PE2) again increases Ds ten-fold but also reduces the effective stratum corneum-viable tissue partition coefficient of the drug to 10% of its unperturbed value. The action of these promoters is shown to be sensitive to the oil-water distribution characteristics of the drug: PE1 is effective for relatively hydrophilic compounds but becomes increasingly ineffectual as a drug lipophilicity increases (log K (moctanol/H2O)≥2); PE2, on the other hand, provides little additional effect over PE1 for hydrophilic substances but significantly enhances the transdermal delivery of hydrophobic moieties. It appears, therefore, that the desirable properties of a penetration enhancer may change depending upon the physico-chemical nature of the drug being delivered.
UR - http://www.scopus.com/inward/record.url?scp=0023195933&partnerID=8YFLogxK
U2 - 10.1016/0168-3659(87)90036-8
DO - 10.1016/0168-3659(87)90036-8
M3 - Article
AN - SCOPUS:0023195933
VL - 5
SP - 43
EP - 51
JO - Journal of Controlled Release
JF - Journal of Controlled Release
SN - 0168-3659
IS - 1
ER -